EUROSLEEP, a network of ENT clinics from Norway and a world leader in the management and treatment of snoring & sleep apnea has joined hands with Nova Specialty Surgery, a leading chain of centers in India offering specialty Surgeries to conduct a “Research Study On Sleep Related Disorders” on the sample consisting of the Indian population. Eurosleep is the largest integrated center for sleep disorders in Europe. Nova is proud to announce its association with Eurosleep for the diagnosis and management of sleep disorders. Sleep disorders are a new area of interest globally, as studies have shown that more and more lifestyle diseases are attributable to sleep disorders.

1. EUROSLEEP & Nova Specialty Surgery Join Hands to Conduct
Research Study on Sleep Disorders in India
*Initiates a National Level Study on World Sleep Day*
MUMBAI – 14th March 2013 – EUROSLEEP, a network of ENT clinics from Norway and a world
leader in the management and treatment of snoring & sleep apnea has joined hands with Nova Specialty
Surgery, a leading chain of centers in India offering specialty surgeries to conduct a “Research Study On
Sleep Related Disorders” on the sample consisting of the Indian population. Eurosleep is the largest
integrated center for sleep disorders in Europe. Nova is proud to announce its association with Eurosleep
for the diagnosis and management of sleep disorders. Sleep disorders are a new area of interest globally,
as studies have shown that more and more lifestyle diseases are attributable to sleep disorders.
Dr. Ashim Desai, Senior Consultant, ENT at Nova Specialty Surgery, Mumbai said, “Although
there is a lot of global data, till now there has been no comprehensive India specific data available
for the Indian population. Therefore the need of the hour is to conduct research studies in this
area. The association of Nova and Eurosleep spread over a large geographic area is ideally suited
to conduct research into the demographics, causes and management of sleep disorders.”
“Globally validated set protocols are being instituted at all centers. Nova’s involvement in this
research aims to achieve complete online data integration, in order to generate meaningful
insights from the collected data for the Indian population”, added Dr. Magne Tvinnereim,
Founder and Global CEO, Eurosleep.
Speaking on the occasion, Suresh Soni, Chairman and CEO of Nova Specialty Surgery,
commented,“ We are delighted with our association with Eurosleep. This partnership will prove
beneficial to both parties in terms of effective health management and knowledge building.”
Dr. Mahesh Reddy, co­founder of Nova Specialty Surgery said, “With this association,
Nova­Eurosleep Sleep Clinics have become the largest provider of diagnostic and therapeutic
modalities for the comprehensive study and management of sleep­related disorders in the country.
It is established simultaneously at five of our of India centers located in Mumbai, New Delhi,

2. Bengaluru, Hyderabad and Ahmedabad.and also at our Muscat Center in the Middle East.
Eurosleep is also going to implemented at our Chennai, Pune, Kanpur and Jaipur centers shortly.
“As a matter of fact, almost 15% of the adult population in Asian countries suffer from sleep
related disorders. However, there is no comprehensive India­specific data. These problems can
give rise to several psychological and physiological changes, besides increasing the risk of
developing hypertension, type II diabetes and an increased body weight,” said Mr. Mohan Nair,
CEO, Eurosleep Asia.
“Over the last year we have been strengthening Eurosleep operations in India by closely working
with specialized clinics and by focusing on spreading the technological know­hows and
advancements. We are extremely hopeful that this tie­up will facilitate research and findings on the
Indian audience on sleep related disorders,” added Mr. Mohan Nair, CEO, Eurosleep Asia.
In fact, sleep apnea is not just a problem of the elderly population as it affects children as well.
Consequences of untreated obstructive sleep apnea among children includes failure to thrive, enuresis,
attention­deficit disorder, behavior problems, poor academic performance, and cardiopulmonary disease.
The most common etiology of obstructive sleep apnea is adenotonsillar hypertrophy. Clinical diagnosis of
obstructive sleep apnea is reliable; however, the gold standard evaluation is overnight polysomnography.
Adenotonsillectomy is curative in most patients. The treatment includes use of continuous positive airway
pressure and weight loss in obese children.
About EUROSLEEP
EUROSLEEP is a world leader in the management and treatment of snoring & sleep apnea and has to its
credit the largest number of patients diagnosed and treated till date. Eurosleep is a network of ENT clinics
from Norway­Bergen, United Kingdom, Aschaffenburg, Bensheim, Berlin, Flensburg, Gottingen,
Hamburg, Hamburg­Suderelbe, Koblenz, Munich, Offenbach, Regensburg and Soltau. Eurosleep is
dedicated to provide complete solutions for sleep related breathing disorders and aims to enhance quality
of life and help patients obtain good health. Eurosleep is led by Dr. Magne Tvinnereim, considered as the
father of modern sleep surgeries who has performed over 15000 CAUP procedures and 30000 sleep
studies.
1.
About Nova Specialty Surgery
Nova Specialty Surgery develops, acquires, owns and operates short­stay surgical centers in partnership
with surgeons across India and the Middle East (in partnership with the OMZEST group). Nova provides
leading surgeons from diverse specialties with comprehensive ultra­modern facilities comprising doctor's
offices, operating rooms, pre and post operative rooms, diagnostics, imaging, health check­up area and a
pathology laboratory. Nova was co­founded by renowned shoulder surgeon Dr. Mahesh Reddy and the
GTI Group, based on a "doctor­owned and doctor­managed" concept enabling doctors to have a sense of
ownership and a long­term association with the company. The Nova infrastructure allows leading surgeons
from diverse specialties to focus solely on the patient's health while the company provides turn­key
hospital management in the form of a full complement of ultra­modern facilities and services. Nova

3. Medical shareholders include, Goldman Sachs, New Enterprise associates, The GTI Capital Group, Dr
Mahesh Reddy and the OMZEST Group.
For more information, please contact:
● Sanjana – sanjana@peregrinepr.in
● Monika – monika@peregrinepr.in